SRPT · CIK 0000873303 · operating
Sarepta Therapeutics, Inc. (SRPT) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.7 billion, Sarepta Therapeutics, Inc. is a small-cap company. The stock currently trades at $16.32, down 2.63% today, with a 52-week range of $10.42–$107.77. The company trades at a forward P/E of 5.3x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-3.93 | $-3.93 | -267.9% | |
| 2024 | $2.34 | $2.47 | +140.3% | |
| 2023 | $-5.80 | $-5.80 | +27.8% | |
| 2022 | $-8.03 | $-8.03 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | $-0.37 | $-0.37 | +0.0% | |
| 2017 | $-0.37 | $-0.37 | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | $-2.36 | $-2.36 | +0.0% | |
| 2012 | $-2.36 | $-2.36 | -11700.0% | |
| 2011 | $-0.02 | $-0.02 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-03-02 | 0001193125-26-084144 | SEC ↗ |
| 2024-12-31 | 2025-02-28 | 0000950170-25-029973 | SEC ↗ |
| 2023-12-31 | 2024-02-28 | 0000950170-24-022036 | SEC ↗ |
| 2022-12-31 | 2023-02-28 | 0000950170-23-005062 | SEC ↗ |
| 2021-12-31 | 2022-03-01 | 0000950170-22-002517 | SEC ↗ |
| 2020-12-31 | 2021-03-01 | 0001564590-21-009835 | SEC ↗ |
| 2019-12-31 | 2020-02-26 | 0001564590-20-006769 | SEC ↗ |
| 2018-12-31 | 2019-02-28 | 0001564590-19-005170 | SEC ↗ |
| 2017-12-31 | 2018-03-01 | 0001564590-18-004107 | SEC ↗ |
| 2016-12-31 | 2017-02-28 | 0001564590-17-002842 | SEC ↗ |
| 2015-12-31 | 2016-02-25 | 0001564590-16-013358 | SEC ↗ |
| 2014-12-31 | 2015-02-26 | 0001193125-15-063997 | SEC ↗ |
| 2013-12-31 | 2014-03-03 | 0001193125-14-080447 | SEC ↗ |
| 2012-12-31 | 2013-03-15 | 0001193125-13-109941 | SEC ↗ |
| 2011-12-31 | 2012-03-13 | 0001193125-12-112142 | SEC ↗ |
| 2010-12-31 | 2011-03-15 | 0001193125-11-066190 | SEC ↗ |